Kyle P Radack,Barbara D Alexander
Kyle P Radack
Solid organ transplantation is emerging as a lifesaving procedure for increasing numbers of patients, and invasive fungal infections are a significant cause of mortality and morbidity for patients undergoing such procedures. Risks for devel...
Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation [0.03%]
基于风险的抗真菌预防在血液系统恶性肿瘤和干细胞移植中的应用
Joshua Wolf,Monica A Slavin
Joshua Wolf
Invasive fungal infection (IFI) is an important cause of morbidity and mortality in patients with hematologic malignancy, prolonged neutropenia, or after hematopoietic stem cell transplant. Antifungal prophylaxis prevents IFI in high-risk h...
Update on invasive opportunistic mycoses: clinical trials review, 2008-2009 [0.03%]
侵袭性条件致病真菌感染的防治研究进展(2008-2009年临床试验回顾)
Andreas H Groll
Andreas H Groll
Invasive fungal infections remain major causes for morbidity and mortality in severely ill or immunocompromised patients. The past decade saw major expansion in the antifungal armamentarium, and the precise role of newer antifungal agents c...